Upon review, we stated that we did not identify an existing pass-through payment category that describes the VersaVue TM Single-Use Flexible Cystoscope
Why Employers Are Zeroing In On GLP-1s The numbers tell the story: 40% of US adults are living with obesity, with projections closer to 50% by 2030 Employers spend $6,472 more per year on employees with obesity than on healthy-weight employees across medical, productivity, disability, and workers comp Individuals who use GLP-1s can lose between 2.5% and 20% of their initial body weight when taking the medication as instructed Employers want to support prevention, not wait until employees are sicker to qualify for care
And the third, involving two healthy people, simply showed that BPC-157 was well tolerated, with no adverse effects
Best for those who want a traditional doctor-patient relationship with the convenience of telehealth
They actively seek out eco-friendly packaging options and work towards reducing their carbon footprint
